Deborah Parks, MD
Fellowship: Rheumatology, Washington University School of Medicine, St. Louis, Missouri 1988
Residency: Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 1985
Medical Degree: University of Louisville School of Medicine, Louisville, Kentucky 1982
Rheumatoid Arthritis, psoriatic arthritis, vasculitis, and systemic lupus erythematosus
Treatment of early inflammatory arthritis such as rheumatoid and psoriatic arthritis and integrating patients’ other medical problems into a comprehensive treatment plan. Educational emphasis is training the fellows in musculoskeletal ultrasonography.
Research and publications
- Parks DL.Tofacitinib kickstarts the novel treatment of rheumatic diseases by kinase inhibitors. The Rheumatologist 2013:7:(6)1
- Singh JA et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis and Rheumatism. In press.